Fingerprint
Dive into the research topics of '10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically